BIO 2014: Proper valuation of IP important in all sectors, says Rader

Learning to determine the value technological advance has contributed requires a great degree of sophistication, Randall Rader said in a session on protecting biotechnology innovations in the US and Latin America at the 2014 BIO International Convention in San Diego, California, yesterday (Tuesday).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

AbbVie blocks Humira antitrust suit

WATCH: Enabling success—mastering s112 in the new era of life sciences patents

AstraZeneca suffers defeat over $7bn diabetes patent

US firm Brownstein nabs five from Crowell ‘at pivotal moment’

American Regent secures rare PI win in Hatch-Waxman dispute

WATCH: Patents s101—how to overcome the current complexity of patent eligibility in the US

In-house with Bayer: ‘Focus on quality early and stay close to inventors’

J&J sues over schizophrenia drug generic following patent victory

BIO 2014: Proper valuation of IP important in all sectors, says Rader

Editor's picks

Editor's picks

More features